CN105394750A - 一种沙棘籽油复方功能保健品 - Google Patents
一种沙棘籽油复方功能保健品 Download PDFInfo
- Publication number
- CN105394750A CN105394750A CN201510776600.1A CN201510776600A CN105394750A CN 105394750 A CN105394750 A CN 105394750A CN 201510776600 A CN201510776600 A CN 201510776600A CN 105394750 A CN105394750 A CN 105394750A
- Authority
- CN
- China
- Prior art keywords
- seed oil
- oil
- functional health
- compound functional
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015112 vegetable and seed oil Nutrition 0.000 title claims abstract description 34
- 230000036541 health Effects 0.000 title claims abstract description 30
- 150000001875 compounds Chemical class 0.000 title claims abstract description 11
- 240000000950 Hippophae rhamnoides Species 0.000 title abstract 3
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 claims abstract description 18
- 239000008280 blood Substances 0.000 claims abstract description 18
- 239000000463 material Substances 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 241000241413 Propolis Species 0.000 claims abstract description 13
- 230000036039 immunity Effects 0.000 claims abstract description 13
- 229940069949 propolis Drugs 0.000 claims abstract description 13
- 229940041678 oral spray Drugs 0.000 claims abstract description 12
- 239000000668 oral spray Substances 0.000 claims abstract description 12
- 230000036772 blood pressure Effects 0.000 claims abstract description 7
- 239000003814 drug Substances 0.000 claims abstract description 6
- 239000000047 product Substances 0.000 claims description 25
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 11
- 239000003921 oil Substances 0.000 claims description 11
- 235000019198 oils Nutrition 0.000 claims description 11
- 235000008524 evening primrose extract Nutrition 0.000 claims description 10
- 239000010475 evening primrose oil Substances 0.000 claims description 10
- 229940089020 evening primrose oil Drugs 0.000 claims description 10
- 239000012467 final product Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 240000000759 Lepidium meyenii Species 0.000 abstract 1
- 235000000421 Lepidium meyenii Nutrition 0.000 abstract 1
- 241000219925 Oenothera Species 0.000 abstract 1
- 235000004496 Oenothera biennis Nutrition 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 230000037213 diet Effects 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 235000013402 health food Nutrition 0.000 abstract 1
- 235000012902 lepidium meyenii Nutrition 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 20
- 238000002474 experimental method Methods 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 10
- 238000003304 gavage Methods 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- -1 oxygen radical Chemical class 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 210000001541 thymus gland Anatomy 0.000 description 5
- 241000282994 Cervidae Species 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001336 alkenes Chemical class 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000021323 fish oil Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 238000012683 free radical ring-opening polymerization Methods 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种沙棘籽油复方功能保健品,由沙棘籽油、蜂胶、玛咖籽油、月见草油为纯天然药食同源材料通过常规的口腔喷雾剂制备方法添加辅料制成口腔喷雾剂,利用它们的协同作用,制成提高免疫力、延缓衰老及降低血糖、血脂、血压的功能性保健食品,产品安全、无副作用,具有显著保健功效,可长期服用,具有很好的市场开发前景。
Description
技术领域
本发明提供一种沙棘籽油复方功能保健品,用于提高人体免疫力和延缓衰老,同时还有降血糖、血脂、血压功能,属于保健食品技术领域。
背景技术
免疫系统的主要功能有三个,即免疫防御,免疫监视和免疫自稳定,其作用为抵抗入侵的病毒和外来微生物及其毒性产物的感染和损害,清除机体内的损伤,衰老,变性组织,摧毁机体内的突变,畸变,病毒感染细胞和恶性新生物。机体的免疫与衰老密切相关,衰老的自由基理论提出,人体受新陈代谢作用的影响时刻产生自由基,对机体产生过氧化损伤,但同时机体又存在着有效的自由基清除系统,使体内自由基维持在正常水平。但受现代社会环境压力和生活压力的影响,人体的免疫力在处于下降状态,进而体内自由基极易处于不平衡状态,过量的活性氧和自由基,会引起DNA损伤而引发基因突变,促进生物大分子交联而使其丧失功能等危害,进而加速人体的衰老。
世界卫生组织将机体无器质性病变,但是有一些功能改变的状态称为“第三状态”,也就是我们俗称的“亚健康状态”。有调查表明,我国目前75%以上的人群处于亚健康状态,这部分人群虽然没有器官、组织功能的病症和缺陷,但是却会感觉身体不适,过度疲劳、活力降低、适应力下降,经常处于焦虑、烦躁、头昏脑胀、食欲不振状态。针对这种情况,越来越多的人开始意识到提高免疫力的重要性,因此抗疲劳提高免疫力的保健品的市场需求和市场容量是巨大的,其社会效益和经济效益也无疑是较好的。
发明内容
本发明提供一种沙棘籽油复方功能保健品,提高人体免疫力和延缓衰老,同时还有降血糖、血脂、血压、清理血管的功能,具有明显的临床疗效。
本发明还公开了一种沙棘籽油复方功能保健品的制备方法,工艺简单、容易操作,生产成本低廉,适用于工业化生产。
本发明所述的一种沙棘籽油复方功能保健品,其特征在于是由以下药物按重量份数比制成的:
沙棘籽油25~45、蜂胶10~25、玛咖籽油10~25、月见草油10~25。
本发明所述的一种沙棘籽油复方保健喷雾剂的制备方法,包括以下步骤:
按比例称取上述原料;沙棘籽油、玛咖籽油、月见草油混合调配成调和油后,再与蜂胶制成油相混合物,再按常规的口腔喷雾剂制备方法添加辅料制成口腔喷雾剂,即得。
【用法用量】口服;2次/日;10~15ml/次。
【适应症】抗衰老;适应于亚健康,血糖、血脂、血压三高人群,免疫力低下。易疲劳、易失眠;性欲低感觉差;体质弱;腰膝乏力;经常健忘;更年期综合症及亚健康人群。
本发明的保健作用分析:
沙棘籽油:净化血液,软化血管,保肝护肝,促进B细胞分泌胰岛素;活血化瘀,抗炎生肌,心脑血管的保护神,防止人体血清胆固醇在血管壁里沉积,防治动脉粥样硬化及心血管疾病的医疗保健效果。沙棘黄酮可以通过清除活性氧自由基起到抗心律失常、抗心肌缺血、缩小心肌梗塞面积、缓解心绞痛、改善心功能的作用。
蜂胶:含有黄酮化合物包括黄酮类、黄酮醇类和双氢黄酮类等,约占蜂胶的4.13%,具有多方面的生理和药理作用,能帮助人体防治多种疾病,使机体各种功能正常化、增强化。蜂胶中的黄酮类化合物,其品种之多、含量之高超过了一般的植物药。对治疗冠心病有效的许多中草药都含有黄酮类化合物。
玛咖籽油:是一种高不饱和度的天然油脂,有效成分为玛咖烯、玛卡酰胺、甾醇、芥子油苷等。改善睡眠,缓解压力,缓解疲劳,激活脑力,增强记忆力。对降低胆固醇、降低血脂、防止动脉粥样硬化、降低脑血栓和心血管疾病的发生有持久作用。α-亚麻酸摄入人体后在酶的作用下可以在人体内转化成二十碳5烯酸(EPA)和二十二碳6烯酸(DHA),它就是深海鱼油的主要成份,因此又叫植物深海鱼油,比深海鱼油更好的是它不含胆固醇,EPA和DHA具有降血脂和提高记忆力的作用。
月见草油:有效成分是伽玛γ-亚麻油酸,内含黄酮、有机酸、生物碱、甾醇类、三萜烯类及各种维生素等140多种生物活性成分。具有抗氧化、抗疲劳、护肝、降血脂作用。
本发明以沙棘籽油为主,稳定安全,具有人体免疫力和延缓衰老功能,加入玛咖籽油、月见草油和蜂胶协同配伍增强了这种功效,且使脂肪酸比例符合营养学标准,防止某些由于油脂摄入不平衡引起的慢性病,可降低动脉硬化的发生。上述各药相互作用,可以补气补血,延缓衰老;可显著提高机体器官功能,快速恢复体力和精力,适应于亚健康,血糖、血脂、血压三高人群,免疫力低下。通过舌下粘膜直接吸收入血液,服用方便,避免被胃酸的分解破坏,也不会被肝脏酶的代谢,保持药效同时也减轻了药物对胃肠道和肝脏的毒副作用。
本发明的积极效果在于:沙棘籽油、蜂胶、玛咖籽油、月见草油为纯天然药食同源材料,利用它们的协同作用,制成提高免疫力、延缓衰老及降低血糖、血脂、血压的功能性保健食品,产品安全、无副作用,具有显著保健功效,可长期服用,具有很好的市场开发前景。
具体实施方式
通过以下实施例进一步举例描述本发明,并不以任何方式限制本发明,在不背离本发明的技术解决方案的前提下,对本发明所作的本领域普通技术人员容易实现的任何改动或改变都将落入本发明的权利要求范围之内。
实施例1
称取沙棘籽油25g、玛咖籽油10g、月见草油10g混合调配成调和油后,再与蜂胶10g制成油相混合物,再按常规的口腔喷雾剂制备方法添加辅料制成口腔喷雾剂,即得。
实施例2
称取沙棘籽油35g、玛咖籽油15g、月见草油15g混合调配成调和油后,再与15g蜂胶制成油相混合物,再按常规的口腔喷雾剂制备方法添加辅料制成口腔喷雾剂,即得。
实施例3
称取沙棘籽油45g、玛咖籽油25g、月见草油25g混合调配成调和油后,再与蜂胶25制成油相混合物,再按常规的口腔喷雾剂制备方法添加辅料制成口腔喷雾剂,即得。
以下实验表明本发明的提高免疫力和延缓衰老作用,其提高免疫活性可以通过淋巴转化实验和对小鼠胸腺、脾脏质量的影响来观察,延缓衰老活性可通过对小鼠血清中MDA,SOD和GSH-Px水平变化来观察。
实验例1
本发明保健品对细胞免疫活性的作用
1实验材料与方法
1.1实验材料
实验动物,采用4周龄的昆明小鼠,体重20±2g,饲养在12h白天/黑夜循环的条件下,温度湿度适宜,喂食标准的颗粒饲料,自由摄食和饮水。本发明保健品(如实施例1~实施例3)由本实验室制备。
1.2实验方法
1.2.1分组:选健康小鼠60只,雌雄各半,分为5组,每组12只。一组为空白对照组,灌胃生理盐水10ml/kg,一组为阳性对照组,灌胃安利纽崔莱蛋白粉50mg/kg,另三组为实验组,灌胃实施例1~实施例3的本发明保健品,分别为120mg/kg,80mg/kg和40mg/kg。
1.2.2MTT实验:将小鼠按1.2.1分组后按每10g体重0.2mL灌胃,每天2次,持续灌胃30天,第31天无菌取脾,于无菌Hank液中制成细胞悬液,200目筛网过滤,Hank液洗3次。用RPMl1640培养液调整细胞浓度为3×106个/mL。而后分两孔加入24孔培养板,每孔1.0mL,一孔加ConA液50μL,一孔作对照,置5%CO2、37℃培养72h。培养结束前4h,每孔吸去上清液0.7mL,加入不含小牛血清的RPMI1640培养液和MTT(5mg/mL,每孔50μL),培养结束后,每孔加入二甲基亚砜200μL,测其在630nm下的吸光度(OD值)。
实验结果:
表1不同组对细胞免疫力活性的影响
结果:本实验本发明保健品高中低剂量组都有提高淋巴细胞免疫力的效果,且高剂量组的效果较阳性对照组还要好些。本发明鹿脾提取物具有辅助提高细胞免疫力的作用。
实验例2
本发明保健品对小鼠胸腺、脾脏质量的影响
2实验材料与方法
2.1实验材料
实验动物,采用4周龄的昆明小鼠,体重20±2g,饲养在12h白天/黑夜循环的条件下,温度湿度适宜,喂食标准的颗粒饲料,自由摄食和饮水。本发明保健品(如实施例2)由本实验室制备。
2.2实验方法
2.2.1分组:选健康小鼠60只,雌雄各半,分为5组,每组12只。一组为空白对照组,灌胃生理盐水10ml/kg,一组为阳性对照组,灌胃安利纽崔莱蛋白粉80mg/kg,另三组为实验组,灌胃高中低三种浓度的本发明保健品,分别为120mg/kg,80mg/kg和40mg/kg。
2.2.2实验
分别设置本发明保健品高、中、低三个浓度组,以及一个空白对照组(以蒸馏水为对照),和阳性对照组,经口给予小鼠不同剂量的鹿脾提取物30天后,与对照组小鼠比较胸腺、脾脏质量的差异。
2.3实验结果:
表2不同的设置组对小鼠胸腺、脾脏质量的影响
结果:从实验数据中可以看出,本实验鹿脾提取物高中低剂量组都有提高小鼠胸腺、脾脏/体重比值的效果,且高剂量组的效果与阳性对照组效果接近。本发明鹿脾提取物具有辅助提高免疫力的作用。
实验例3
本发明保健品对小鼠体内MDA,SOD和GSH-Px水平变化情况
3实验材料与方法
3.1实验材料
实验动物,采用4周龄的昆明小鼠,体重20±2g,饲养在12h白天/黑夜循环的条件下,温度湿度适宜,喂食标准的颗粒饲料,自由摄食和饮水。本发明保健品(如实施例2)由本实验室制备。
3.2实验方法
3.2.1分组:选健康小鼠48只,雌雄各半,分为4组,每组12只。一组为空白对照组,灌胃生理盐水10ml/kg,另三组为实验组,灌胃高中低三种浓度的本发明保健品,分别为120mg/kg,80mg/kg和40mg/kg。
3.2.2实验
分别设置本发明保健品高、中、低三个浓度组,以及一个空白对照组(以蒸馏水为对照),经口给予小鼠不同剂量的本发明保健品30天后,与对照组小鼠比较血清中MDA,SOD和GSH-Px的水平变化。
3.3实验结果:
表3不同的设置组对小鼠血清中MDA,SOD和GSH-Px的水平的影响
结果:从实验数据中可以看出,本发明保健品高中低剂量组都可以降低小鼠血清中的MDA含量,提高血清中SOD和GSH-Px的水平,说明本发明可以减少小鼠体内的氧自由基,提高抗氧化活性,进而说明本发明具有辅助延缓衰老的效果。
Claims (3)
1.一种沙棘籽油复方功能保健品,其特征在于是由以下药物按重量份数比制成的:
沙棘籽油25~45、蜂胶10~25、玛咖籽油10~25、月见草油10~25。
2.权利要求1所述的一种沙棘籽油复方功能保健品的制备方法,包括以下步骤:
按比例称取上述原料;沙棘籽油、玛咖籽油、月见草油混合调配成调和油后,再与蜂胶制成油相混合物,再按常规的口腔喷雾剂制备方法添加辅料制成口腔喷雾剂,即得。
3.权利要求1所述的一种沙棘籽油复方功能保健品在提高免疫力、延缓衰老及降低血糖、血脂、血压的医用用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510776600.1A CN105394750A (zh) | 2015-11-16 | 2015-11-16 | 一种沙棘籽油复方功能保健品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510776600.1A CN105394750A (zh) | 2015-11-16 | 2015-11-16 | 一种沙棘籽油复方功能保健品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105394750A true CN105394750A (zh) | 2016-03-16 |
Family
ID=55460797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510776600.1A Pending CN105394750A (zh) | 2015-11-16 | 2015-11-16 | 一种沙棘籽油复方功能保健品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105394750A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106420860A (zh) * | 2016-12-13 | 2017-02-22 | 南京中科药业有限公司 | 一种含有沙棘油和蜂胶的药物组合物 |
CN107156332A (zh) * | 2017-06-22 | 2017-09-15 | 利康行(北京)生物科技有限公司 | 一种增强免疫力的复方保健品 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050087306A (ko) * | 2004-02-26 | 2005-08-31 | 김천수 | 전립선 및 방광을 위한 건강식품 제조방법 |
CN1742752A (zh) * | 2005-10-08 | 2006-03-08 | 晏四平 | 含有药用植物油的喷雾剂 |
CN100998406A (zh) * | 2006-12-18 | 2007-07-18 | 东北虎药业股份有限公司 | 增强免疫力、对胃粘膜损伤有保护功能的保健食品及其制备方法 |
CN102669669A (zh) * | 2012-05-30 | 2012-09-19 | 吉林大学 | 一种鹿脾提取物制剂及其制备方法 |
CN104479857A (zh) * | 2014-12-05 | 2015-04-01 | 周连平 | 玛咖籽油的提取方法 |
-
2015
- 2015-11-16 CN CN201510776600.1A patent/CN105394750A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050087306A (ko) * | 2004-02-26 | 2005-08-31 | 김천수 | 전립선 및 방광을 위한 건강식품 제조방법 |
CN1742752A (zh) * | 2005-10-08 | 2006-03-08 | 晏四平 | 含有药用植物油的喷雾剂 |
CN100998406A (zh) * | 2006-12-18 | 2007-07-18 | 东北虎药业股份有限公司 | 增强免疫力、对胃粘膜损伤有保护功能的保健食品及其制备方法 |
CN102669669A (zh) * | 2012-05-30 | 2012-09-19 | 吉林大学 | 一种鹿脾提取物制剂及其制备方法 |
CN104479857A (zh) * | 2014-12-05 | 2015-04-01 | 周连平 | 玛咖籽油的提取方法 |
Non-Patent Citations (2)
Title |
---|
张飞,等: "几种颇具潜力的特种植物油", 《中国油脂》 * |
许牡丹,等: "《药食兼用食品加工技术》", 31 May 2006, 化学工业出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106420860A (zh) * | 2016-12-13 | 2017-02-22 | 南京中科药业有限公司 | 一种含有沙棘油和蜂胶的药物组合物 |
CN107156332A (zh) * | 2017-06-22 | 2017-09-15 | 利康行(北京)生物科技有限公司 | 一种增强免疫力的复方保健品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017101878A4 (en) | Gynostemma pentaphyllum containing health care pharmaceutical composition for preventing hyperlipidemia, hypertension, hyperglycemia, and gout | |
BAYATI et al. | Component and application Aloe vera plant in medicine | |
CN104739925A (zh) | 一种治疗痤疮的组合物及其制备方法 | |
CN101411488A (zh) | 人参果茶 | |
CN105664140A (zh) | 一种糖肽组合物及其制备方法和用途 | |
Williams | Moringa olefiera: Could this be an Answer to our Need for an Alternative to Fighting Drug-Resistance and Chronic Infections | |
CN104799286A (zh) | 一种用于提高免疫力的组合物及其制备方法 | |
CN102659917A (zh) | 一种从松花粉中分离制备粗蛋白及酶解肽类的方法 | |
CN107007646A (zh) | 一种辅助防治癌症的营养复合物 | |
CN105477100A (zh) | 一种灵芝孢子油复方保健喷雾剂及制备方法 | |
CN105394750A (zh) | 一种沙棘籽油复方功能保健品 | |
Stevens et al. | Utilization potentials of Moringa oleifera in Nigeria: a preliminary assessment | |
De Zoysa | Nutritional value, bioactive compounds, and health-promoting properties of abalone | |
CN1985917B (zh) | 用于降血糖、降血脂、控制糖尿病并发症的组合物 | |
CN100334972C (zh) | 一种保健品及其生产方法 | |
JP2004352626A (ja) | 植物由来成分を含有する抗コレステロール剤 | |
Iermolenko et al. | Theoretical justification of the search for potential medicinal products containing food plant biologically active substances | |
CN103610742A (zh) | 一种具有抗肿瘤功效的灵芝孢子油组合物及其制备工艺 | |
CN103262940A (zh) | 一种黄粉虫复合蛋白制品及制备方法 | |
CN106668077A (zh) | 海洋生物活性组合物及药用制剂 | |
CN111165694B (zh) | 一种复合黑菊芋功能营养液及其制备方法 | |
CN106819223A (zh) | 一种保健奶茶及其制备方法 | |
CN105285980B (zh) | 一种红花籽油复方保健喷雾剂及制备方法 | |
CN105285977A (zh) | 一种具有抗衰老、提高免疫力功效的保健品 | |
CN107970437A (zh) | 虫草克癌基因肽 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160316 |